Biotech Stock 365% This: Big Bet on 3-NDA Strategy
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
Deciding between broad market and sector funds depends on diversification needs and risk tolerance. This guide compares outcomes and helps you decide.
28,547 articlesA focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
Bitcoin climbs as a tentative Iran peace framework sparks risk-on buying. Japan's ETF market shows steady inflows, wh...
Binance withdraws its MiCA filing in Greece, signaling a broader EU strategy as July 1 approaches. European users fac...
The NEOS Nasdaq-100 High Income ETF (QQQI) is delivering a high monthly payout via an option overlay, but the strateg...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
Missed Sandisk's 580% rally? No worry. You can still ride the AI-driven chip surge with three smart stock picks, clea...
FactSet (FDS) investors are eyeing the Q3 2026 earnings with questions about growth, margins, and product strategy. T...
Scorpio Tankers has moved from a debt-laden balance sheet to net cash of roughly $334 million by early 2026, a develo...
CrowdStrike just split stock, turning a high-priced share into four easier-to-access pieces. A lower price can spark ...
This article dives into amerisafe (amsf) 2025 earnings expectations, outlining key drivers, potential pitfalls, and a...
Shiba Inu showed a notable, double-digit climb this week. This guide breaks down the catalysts—ecosystem upgrades, se...
As Rivian gears up for the upcoming earnings release, two major catalysts could shape the stock's trajectory. This gu...